(1 - 12 from 16
)
StemCells names Stephen Huhn, M.D. to Chief Medical Officer STEM -...
thefly.com
Stephen Huhn, M.D., F.A.C.S., F.A.A.P. has been promoted to the newly created position of vice president, CNS clinical research and Chief ...
Macular Degeneration Stem Cell Clinical Trial Results Allow ...retinafoundation.org › news › amd-2
retinafoundation.org
Stephen Huhn, Vice President of Clinical Research and Chief Medical Officer of StemCells, Inc. states, “the first active site is enrolling and we plan to have ...
StemCells, Inc. Presents Two-Year Pelizaeus-Merzbacher Disease (PMD)...
www.globenewswire.com
The data was presented today by Stephen Huhn, MD, FACS, FAAP, Vice President, CNS Clinical Research at StemCells, Inc., at the
StemCells, Inc. Discontinues Batten Disease Program - Business -...
www.nbcnews.com
Stephen Huhn, MD, FACS, FAAP, Vice President and Head of the CNS Program at StemCells, Inc., stated, "In clinical trials for rare diseases, ...
sorted by relevance / date